Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
-
Scotland thrash Tonga in Autumn Nations finale
-
Three key Irish takeaways from Autumn Nations Series
-
Imperious Shiffrin swoops to 103rd win at Gurgl
-
Schmidt challenges Wallabies to 'roll up their sleeves' after gruesome year
-
Washington seeking to 'iron out' Trump proposal details with Ukrainians in Geneva
-
South African centurion Muthusamy celebrates 'awesome' Test journey
-
Brazil 'very concerned' about US naval build-up near Venezuela
-
Liverpool a 'mess' says Van Dijk
-
First blind women's T20 cricket World Cup boosts sport
-
France eye Dupont boost for Six Nations defence
-
McLaren boss apologises to Norris, Piastri for Vegas disqualification
-
G20 grapples with splintering world order
-
Verstappen wins big in Vegas with McLarens disqualified
-
Muthusamy, Jansen put South Africa on top in second India Test
-
Rubio lands in Geneva for talks on Ukraine plan
-
Norris and Piastri disqualified from Las Vegas GP
-
Slovenia holds crunch vote on contested assisted dying law
-
Aonishiki beomes first Ukrainian to win sumo tournament
-
Holders Australia drawn with New Zealand in Rugby League World Cup
-
Vietnam flooding kills at least 90
-
Muthusamy's maiden Test century powers South Africa to 428-7
-
Myanmar junta says nearly 1,600 foreigners arrested in scam hub raids
-
US signals room for negotiation on Ukraine plan ahead of talks
-
Verstappen wins Las Vegas F1 Grand Prix, Norris edges closer to crown
-
Muthusamy anchors South Africa to 316-6 in second India Test
-
Vietnam flood death toll rises to 90
-
US denies pushing Russian 'wish list' as Ukraine plan
-
Harden's 55 leads Clippers win as Pistons streak hits 12
-
Kim's first top-10 in 14 years as Ballester wins maiden pro title
-
Gotham crowned NWSL champions after Lavelle breaks Spirit
-
Trump signals room for negotiation on Ukraine plan ahead of talks
-
Head shapes up as solution for Australia's opening woes
-
Tomorrowland bets on Chinese dance music fans with first indoor event
-
England slammed as 'brainless' after first Ashes Test capitulation
-
Slovenia to hold new vote on contested assisted dying law
-
10 Benefits of Choosing Dental Implants After an Extraction
-
SKYLINE Announces Q3 2025 Financial Results
-
'Beer tastes better' for Eramsus after win over Irish
-
No.1 Jeeno leads by six at LPGA Tour Championship
-
Neres double fires Napoli top in Italy
-
Bielle-Biarrey masterclass helps France hold off Australia
-
Pogba returns in Monaco loss as PSG stay top in France
-
COP30: Key reactions to climate deal
-
What did countries agree to at COP30?
-
Harden's club-record 55 points leads Clippers over Hornets
-
Amazon climate deal a 'win' for global unity but fossil fuels untouched
-
Boos, blowups and last-minute pause as a chaotic COP30 closes out
-
Farrell proud of Ireland after 'mad' Test with South Africa
-
Gaza civil defence says 21 killed in Israeli strikes
-
South Africa beat ill-disciplined Irish to end Dublin drought
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Piper Sandler's 37th Annual Healthcare Conference, on Tuesday, December 2nd at 11:00am ET
A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
Y.Nakamura--AMWN
